SEC Form 4 · accession 0000899243-16-024608
Inhibitor Therapeutics, Inc. · INTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel P Sears Jr.
Director
Period of report
Jul 1, 2016
Accepted (ET)
Jul 6, 2016 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042418
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jul 1, 2016 | A | 150,000 | A | — | — | Common Stock | 150,000 | 150,000 | D |
| Options to Purchase Common StockF3 | $0.24 | Jul 1, 2016 | A | 150,000 | A | — | Jul 1, 2026 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a right to receive one share of the issuer's common stock.
- F2The RSUs were issued to the reporting person on July 1, 2016, pursuant to a grant under the issuer's 2014 Equity Incentive Plan. The RSUs will vest in three equal annual installments beginning on the first anniversary of the date of grant, provided that if such vesting date is not during an open trading window, then such RSUs will vest on the first day thereafter that is during an open trading window.
- F3The options become exercisable in three equal annual installments beginning on the first anniversary of the date of grant.